Literature DB >> 33860767

[Haptoglobin as a biomarker].

S N Naryzhny1, O K Legina2.   

Abstract

Haptoglobin (Hp) is a blood plasma glycoprotein that binds free hemoglobin (Hb) and plays a critical role in tissue protection and the prevention of oxidative damage. In addition, it has a number of regulatory functions. Haptoglobin is an acute phase protein, its concentration in plasma changes in pathology, and the test for its concentration is part of normal clinical practice. Haptoglobin is a conservative protein synthesized mainly in the liver and lungs and is the subject of research as a potential biomarker of many diseases, including various forms of malignant neoplasms. Haptoglobin has several unique biophysical characteristics. Only in humans, the Hp gene is polymorphic, has three structural alleles that control the synthesis of three major phenotypes of Hp, homozygous Hp1-1 and Hp2-2, and heterozygous Hp2-1, determined by a combination of allelic variants that are inherited. Numerous studies indicate that the phenotype of haptoglobin can be used to judge the individual's predisposition to various diseases. In addition, Hp undergoes various post-translational modifications (PTMs). These are structural transformations (removal of the signal peptide, cutting of the Pre-Hp precursor molecule into two subunits, α and β, limited proteolysis of α-chains, formation of disulfide bonds, multimerization), as well as chemical modifications of α-chains and glycosylation of the β-chain. Glycosylation of the β-chain of haptoglobin at four Asn sites is the most important variable PTM that regulates the structure and function of the glycoprotein. The study of modified oligosaccharides of the Hp β-chain has become the main direction in the study of pathological processes, including malignant neoplasms. Many studies are focused on the identification of PTM and changes in the level of the α2-chain of this protein in pathology. These characteristics of Hp indicate the possibility of the existence of this protein as different proteoforms, probably with different functions. This review is devoted to the description of the structural and functional diversity of Hp and its potential use as a biomarker of various pathologies.

Entities:  

Keywords:  biomarker; haptoglobin

Mesh:

Substances:

Year:  2021        PMID: 33860767     DOI: 10.18097/PBMC20216702105

Source DB:  PubMed          Journal:  Biomed Khim        ISSN: 2310-6905


  5 in total

1.  Special electromagnetic field-treated water and far-infrared radiation alleviates lipopolysaccharide-induced acute respiratory distress syndrome in rats by regulating haptoglobin.

Authors:  Changyong Luo; Yan Li; Xu Liang; Yifan Chen; Qiao Zou; Yurong Kong; Zhengguang Guo; Wei Sun; Xin Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

Authors:  Mi-Kyung Oh; Hansol Joo; In-Sook Kim
Journal:  PLoS One       Date:  2022-05-17       Impact factor: 3.240

3.  Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer.

Authors:  Yajin Niu; Jun Xue; Xueliang Wu; Ming Qu; Likun Wang; Weizheng Liang; Tian Li
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

4.  Clinical and Diagnostic Significance of Sialic Acids Determination in Biological Material.

Authors:  I V Volkhina; E G Butolin
Journal:  Biochem Mosc Suppl B Biomed Chem       Date:  2022-08-15

5.  Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.

Authors:  Stanislav Naryzhny; Natalia Ronzhina; Elena Zorina; Fedor Kabachenko; Nikolay Klopov; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.